Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
FDA outlines draft policy on MRD for accelerated approval
The guidance provides recommendations for designing clinical trials that use MRD or CR as endpoints for accelerated approval in multiple myeloma.
Angus Liu
Jan 21, 2026 2:55pm
Fierce Pharma
Pfizer CEO blasts RFK Jr. over 'anti-science' vaccine stance: WSJ
Jan 21, 2026 11:01am
Sponsored
ExamOne executive details how mobile phlebotomy is reshaping clinical research
Jan 19, 2026 8:00am
Inside Beam's 'big push' for in vivo gene editing
Jan 21, 2026 7:52am
Sponsored
iRegene Secures Historic FDA RMAT for Parkinson’s iPSC Therapy
Jan 19, 2026 8:00am
Novo hands diabetes assets to Aspect amid cell therapy retreat
Jan 21, 2026 10:13am
More News
Fierce Biotech Fundraising Tracker 2026: Think Bio & more
Jan 21, 2026 9:30am
Cancer imaging company buys Lisata for ph. 2-stage tumor drug
Jan 21, 2026 9:20am
IO mulls more layoffs months after halving head count
Jan 21, 2026 7:20am
Insilico agrees to $66M deal to split rights for NLRP3 inhibitor
Jan 21, 2026 7:05am
See more stories